Nucleoside/nucleobase transport and metabolism by microvascular endothelial cells isolated from ENT1-/- mice

Derek B J Bone, Doo Sup Choi, Imogen R. Coe, James R. Hammond

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Nucleoside and nucleobase uptake is integral to mammalian cell function, and its disruption has significant effects on the cardiovasculature. The predominant transporters in this regard are the equilibrative nucleoside transporter subtypes 1 (ENT1) and 2 (ENT2). To examine the role of ENT1 in more detail, we have assessed the mechanisms by which microvascular endothelial cells (MVECs) from ENT1-/- mice transport and metabolize nucleosides and nucleobases. Wild-type murine MVECs express mainly the ENT1 subtype with only trace levels of ENT2. These cells also have a Na+-independent equilibrative nucleobase transport mechanism for hypoxanthine (ENBT1). In the ENT1-/- cells, there is no change in ENT2 or ENBT1, resulting in a very low level of nucleoside uptake in these cells, but a high capacity for nucleobase accumulation. Whereas there were no significant changes in nucleoside transporter subtype expression, there was a dramatic increase in adenosine deaminase and adenosine A2a receptors (both transcript and protein) in the ENT1-/- tissues compared with WT. These changes in adenosine deaminase and A2a receptors likely reflect adaptive cellular mechanisms in response to reduced adenosine flux across the membranes of ENT1-/- cells. Our study also revealed that mouse MVECs have a nucleoside/nucleobase transport profile that is more similar to human MVECs than to rat MVECs. Thus mouse MVECs from transgenic animals may prove to be a useful preclinical model for studies of the effects of purine metabolite modifiers on vascular function.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume299
Issue number3
DOIs
StatePublished - Sep 2010

Fingerprint

Equilibrative Nucleoside Transporter 1
Nucleosides
Endothelial Cells
Adenosine Deaminase
Equilibrative-Nucleoside Transporter 2
Nucleoside Transport Proteins
Genetically Modified Animals
Purinergic P1 Receptors
Hypoxanthine
Adenosine
Blood Vessels
mouse SLC29A1 protein
Membranes

Keywords

  • Adenosine
  • Equilibrative nucleoside transporter
  • Heart
  • Microvasculature
  • Transgenic

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Nucleoside/nucleobase transport and metabolism by microvascular endothelial cells isolated from ENT1-/- mice. / Bone, Derek B J; Choi, Doo Sup; Coe, Imogen R.; Hammond, James R.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 299, No. 3, 09.2010.

Research output: Contribution to journalArticle

@article{b763d3beff0148e5acdb5249f3097bc2,
title = "Nucleoside/nucleobase transport and metabolism by microvascular endothelial cells isolated from ENT1-/- mice",
abstract = "Nucleoside and nucleobase uptake is integral to mammalian cell function, and its disruption has significant effects on the cardiovasculature. The predominant transporters in this regard are the equilibrative nucleoside transporter subtypes 1 (ENT1) and 2 (ENT2). To examine the role of ENT1 in more detail, we have assessed the mechanisms by which microvascular endothelial cells (MVECs) from ENT1-/- mice transport and metabolize nucleosides and nucleobases. Wild-type murine MVECs express mainly the ENT1 subtype with only trace levels of ENT2. These cells also have a Na+-independent equilibrative nucleobase transport mechanism for hypoxanthine (ENBT1). In the ENT1-/- cells, there is no change in ENT2 or ENBT1, resulting in a very low level of nucleoside uptake in these cells, but a high capacity for nucleobase accumulation. Whereas there were no significant changes in nucleoside transporter subtype expression, there was a dramatic increase in adenosine deaminase and adenosine A2a receptors (both transcript and protein) in the ENT1-/- tissues compared with WT. These changes in adenosine deaminase and A2a receptors likely reflect adaptive cellular mechanisms in response to reduced adenosine flux across the membranes of ENT1-/- cells. Our study also revealed that mouse MVECs have a nucleoside/nucleobase transport profile that is more similar to human MVECs than to rat MVECs. Thus mouse MVECs from transgenic animals may prove to be a useful preclinical model for studies of the effects of purine metabolite modifiers on vascular function.",
keywords = "Adenosine, Equilibrative nucleoside transporter, Heart, Microvasculature, Transgenic",
author = "Bone, {Derek B J} and Choi, {Doo Sup} and Coe, {Imogen R.} and Hammond, {James R.}",
year = "2010",
month = "9",
doi = "10.1152/ajpheart.00018.2010",
language = "English (US)",
volume = "299",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Nucleoside/nucleobase transport and metabolism by microvascular endothelial cells isolated from ENT1-/- mice

AU - Bone, Derek B J

AU - Choi, Doo Sup

AU - Coe, Imogen R.

AU - Hammond, James R.

PY - 2010/9

Y1 - 2010/9

N2 - Nucleoside and nucleobase uptake is integral to mammalian cell function, and its disruption has significant effects on the cardiovasculature. The predominant transporters in this regard are the equilibrative nucleoside transporter subtypes 1 (ENT1) and 2 (ENT2). To examine the role of ENT1 in more detail, we have assessed the mechanisms by which microvascular endothelial cells (MVECs) from ENT1-/- mice transport and metabolize nucleosides and nucleobases. Wild-type murine MVECs express mainly the ENT1 subtype with only trace levels of ENT2. These cells also have a Na+-independent equilibrative nucleobase transport mechanism for hypoxanthine (ENBT1). In the ENT1-/- cells, there is no change in ENT2 or ENBT1, resulting in a very low level of nucleoside uptake in these cells, but a high capacity for nucleobase accumulation. Whereas there were no significant changes in nucleoside transporter subtype expression, there was a dramatic increase in adenosine deaminase and adenosine A2a receptors (both transcript and protein) in the ENT1-/- tissues compared with WT. These changes in adenosine deaminase and A2a receptors likely reflect adaptive cellular mechanisms in response to reduced adenosine flux across the membranes of ENT1-/- cells. Our study also revealed that mouse MVECs have a nucleoside/nucleobase transport profile that is more similar to human MVECs than to rat MVECs. Thus mouse MVECs from transgenic animals may prove to be a useful preclinical model for studies of the effects of purine metabolite modifiers on vascular function.

AB - Nucleoside and nucleobase uptake is integral to mammalian cell function, and its disruption has significant effects on the cardiovasculature. The predominant transporters in this regard are the equilibrative nucleoside transporter subtypes 1 (ENT1) and 2 (ENT2). To examine the role of ENT1 in more detail, we have assessed the mechanisms by which microvascular endothelial cells (MVECs) from ENT1-/- mice transport and metabolize nucleosides and nucleobases. Wild-type murine MVECs express mainly the ENT1 subtype with only trace levels of ENT2. These cells also have a Na+-independent equilibrative nucleobase transport mechanism for hypoxanthine (ENBT1). In the ENT1-/- cells, there is no change in ENT2 or ENBT1, resulting in a very low level of nucleoside uptake in these cells, but a high capacity for nucleobase accumulation. Whereas there were no significant changes in nucleoside transporter subtype expression, there was a dramatic increase in adenosine deaminase and adenosine A2a receptors (both transcript and protein) in the ENT1-/- tissues compared with WT. These changes in adenosine deaminase and A2a receptors likely reflect adaptive cellular mechanisms in response to reduced adenosine flux across the membranes of ENT1-/- cells. Our study also revealed that mouse MVECs have a nucleoside/nucleobase transport profile that is more similar to human MVECs than to rat MVECs. Thus mouse MVECs from transgenic animals may prove to be a useful preclinical model for studies of the effects of purine metabolite modifiers on vascular function.

KW - Adenosine

KW - Equilibrative nucleoside transporter

KW - Heart

KW - Microvasculature

KW - Transgenic

UR - http://www.scopus.com/inward/record.url?scp=77956675860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956675860&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00018.2010

DO - 10.1152/ajpheart.00018.2010

M3 - Article

C2 - 20543083

AN - SCOPUS:77956675860

VL - 299

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 3

ER -